PharmaSeek 2018 Highlights

PharmaSeek continues to be a leader in our industry as a resource for new study opportunities for sites. This past year has also afforded us an opportunity to produce extensions of our knowledge base in the form of routine blog posts to help educate others in the industry. We still strive to be among the best at expediting study start times and we were able to keep that mission alive by creating new ways to accomplish this. We have seen the development of several new service lines that can help ease the responsibilities of our clients and take some of the day-to-day burdens off their shoulders. This expansion in services has us very excited about the year to come.

Read More
Applying Behavioral Economics to Clinical Trial Negotiations

While the structure of clinical studies follows logic and reason, the business of clinical trials may not be as rational. Traditional economic thought assumes humans to be rational, self-serving decision-makers; however, the growing field of behavioral economics shows us that rationality might not be our forte. In this article, we will use a framework of behavioral economics to explore how our cognitive biases and subjective experiences impact our decisions, and how becoming aware of these influences can improve our clinical trial negotiations.

Read More
PharmaSeek CompaniesComment
Tradeshows: Are They Worth the Investment?

Fall is here, which means tradeshow season is upon us! These industry events are valuable educational and networking opportunities. Even so, registration fees, travel, lodging, and meal expenses for employees require financial planning. With so much to consider in terms of dollars spent, are tradeshows really worth it? This article will explore five reasons why, even with all the added costs, it’s worthwhile for research sites to attend tradeshows.

Read More
PharmaSeek CompaniesComment
Reduce Drug Development Costs Through a Protocol Cost Savings Analysis

Pharmaceutical companies, biotech firms, and anyone in the business of developing new therapeutics knows there is significant pressure to reduce the cost of research and development (R&D) while delivering treatments and devices that safely and effectively alleviate symptoms, deliver medications or cure medical conditions—all while maintaining billing compliance. Luckily, utilizing a Protocol Cost Savings Analysis (PCSA) eases some of that pressure, allowing your organization to focus on creating innovative therapeutics that lead to positive patient outcomes.   

Read More
Site Selection Tips: How to Make Your Site Stand Out

In today’s clinical research industry, sponsors are under increased pressure to cut waste and tighten their budgets. This has made the site selection process highly competitive, especially given the market’s rapid trend toward globalization. Luckily, there are steps you can take that can help increase your odds of selection, while simultaneously making your site a more efficient conductor of clinical trials. This article will discuss four tips to help your site stand out in the selection process.

Read More
Using Social Media for Patient Recruitment: How to Reach Your Ideal Patient  

Social media is an increasingly popular mode of communication. By 2019, it is estimated that around 2.77 billion people worldwide will have active social media accounts.1 This means that patient recruitment must have a space in the social media world, but with so much information competing for users’ attention online, is it enough to simply place an ad or create a post about your study? While we have written about Facebook’s potential for patient recruitment in previous articles, this post will discuss how to let your ideal patient guide your social media recruitment efforts across a variety of social platforms.

Read More
Traditional vs. Digital: Diversifying Patient Recruitment Funds Across Media

As we all know, patient recruitment isn’t a straightforward process, and the investment of time and money can be quite large. While digital media can be an efficient and economical advertising realm, investing solely in digital advertisements could result in a failure to reach many potential patients. Perhaps surprisingly, a one-handed advertising approach could affect your site’s credibility. This blog explores how diversifying your advertising dollars across both traditional and digital media can help you reach potential patients.

Read More
Using Facebook Ads for Patient Recruitment: How to Select an Audience

Facebook’s vast and diverse user population provides an invaluable resource for patient recruitment, but without the right audience, it will be nearly impossible for patients to find your study. In this blog, we will discuss how to select the right audience for your ads in order to get the most out of your Facebook advertisements.

Read More
Using Facebook Ads for Patient Recruitment: How to Create Ads with Strong Visual Imagery and Good Calls to Action

With over 1.15 billion active users, Facebook is becoming an increasingly important way for clinical research sites to recruit patients for their studies. While patient populations certainly exist on Facebook, connecting with them on the world’s largest social network isn’t always easy. In order for patients to find your study in an online space already saturated with ads, creating advertisements with strong visual imagery and good calls to action is vital.

Read More
The Pros and Cons of Different PI Compensation Models

A frequent question asked in our industry is: "How much should we pay investigators for their work on a clinical trial, and what methodology should be used?"  While this question seems straightforward, it is quite complex. The amount and method by which you pay investigators can play a big role in the success, or lack thereof, of your site. 

Read More
Clinical Research Coordinators: The Glue that Binds a Clinical Research Program

Clinical research coordinators are an incredibly important part of the clinical research process. Their role has continued to evolve in recent years, as clinical trials have continued to grow in complexity. This evolved role has led to better data collection, greater protocol compliance, and overall improved subject safety. Because of their crucial role, many have come to recognize clinical research coordinators as the glue that binds clinical research programs.

Read More
May News Roundup: What’s New in Research?

Stem Cells Edited to Fight Arthritis – Read More >

Researchers at the Washington University School of Medicine and Shriners Hospitals for Children have rewired stem cells from mice in an effort to reduce inflammation caused by arthritis and other conditions. These stem cells are developed into cartilage cells that produce a biologic anti-inflammatory drug that may be able to replace arthritic cartilage, protecting joints and other tissues from further damage.

Read More
3 Tips for Site Selection

Site selection is a complex process composed of multiple factors on which research sites are evaluated. It may seem as if your success is solely in the hands of sponsors and CROs, but there are several things you can do to help your site get selected on more studies. Here are three tips from the site selection and business development team at PharmaSeek:

Read More
3 Tips for Negotiating Advertising Budgets

Advertising plays an important role when it comes to recruiting patients for clinical trials, but it’s often underutilized by sites or not used at all. Whether this is due to a lack of internal staffing or expertise, there is a lot of potential going untapped when sites bypass study advertising.

Read More
February News Roundup: What's New in Research?

World’s Smallest Pacemaker Revealed – Read More >

The Micra Transcatheter Pacing System (TPS), a new pacemaker the size of a nickel, can now be implanted in patients with bradycardia to help pump enough blood through the body during physical activity. The tiny device is just 1/10th the size of a traditional pacemaker, and it is currently the only leadless pacemaker approved for use in the United States. The TPS is also unique in that it doesn’t require cardiac wires or a surgical pocket under the skin to deliver a pacing therapy.

Read More
Subject Injury Language: What You Need to Know

One of the negative aspects of clinical trials is the possibility that a patient will suffer an injury or illness as a result of their study participation. As such, one of the most important pieces of a contract is the subject injury language. ‘Subject Injury’ is defined as an injury, illness, adverse event/reaction, or death caused by a study subject’s involvement in a clinical research study. Prior to the study, the research site and the study sponsor should come to an agreement on what exactly constitutes a Subject Injury, and who pays in the event of a Subject Injury.

Read More